Zobrazeno 1 - 10
of 130
pro vyhledávání: '"KA Wafford"'
Publikováno v:
British Journal of Pharmacology. 168:1118-1132
Background and Purpose Most GABAA receptor subtypes comprise 2α, 2β and 1γ subunit, although for some isoforms, a δ replaces a γ-subunit. Extrasynaptic δ-GABAA receptors are important therapeutic targets, but there are few suitable pharmacologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02fe010bfa813c69ea6bb2da20239123
https://doi.org/10.1111/bph.12001
https://doi.org/10.1111/bph.12001
Publikováno v:
Europe PubMed Central
The effects of gamma-hexachlorocyclohexane (gamma-HCH) and its alpha, beta and delta isomers on the gamma-aminobutyric acid (GABA) responses of human alpha1beta3gamma2S and alpha6beta3gamma2S GABA(A) receptors expressed in Xenopus oocytes were examin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::20b22e44afac51bd42f1e82ac529760e
http://europepmc.org/abstract/med/9316872
http://europepmc.org/abstract/med/9316872
Autor:
McCarthy AP; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.) mccarthy_andrew_peter@lilly.com., Svensson KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Shanks E; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Brittain C; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Eastwood BJ; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Kielbasa W; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Biglan KM; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Wafford KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 Mar; Vol. 380 (3), pp. 143-152. Date of Electronic Publication: 2021 Dec 10.
Autor:
Wafford KA; Slowave Therapeutics Ltd, 113 York Road, Woking GU22 7XR, UK.
Publikováno v:
Cerebral circulation - cognition and behavior [Cereb Circ Cogn Behav] 2021 Aug 13; Vol. 2, pp. 100025. Date of Electronic Publication: 2021 Aug 13 (Print Publication: 2021).
Autor:
Holton CM; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Hanley N; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Shanks E; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Oxley P; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., McCarthy A; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Eastwood BJ; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Murray TK; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Nickerson A; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK., Wafford KA; Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK. kwafford@slowavetx.co.uk.
Publikováno v:
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Jul 15; Vol. 12 (1), pp. 84. Date of Electronic Publication: 2020 Jul 15.
Autor:
Hanley N; Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK., Paulissen J; Clinical Division, Syneos Health (previously INC Research/InVentiv Health), Ann Arbor, MI., Eastwood BJ; Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK., Gilmour G; Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK., Loomis S; Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK., Wafford KA; Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK., McCarthy A; Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, UK.
Publikováno v:
Sleep [Sleep] 2019 Sep 06; Vol. 42 (9).
Autor:
Nollet M; Surrey Sleep Research Centre, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom.; Lilly Research Centre, Erl Wood Manor, Eli Lilly and Company, GU20 6PH Windlesham, United Kingdom., Hicks H; Surrey Sleep Research Centre, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom., McCarthy AP; Lilly Research Centre, Erl Wood Manor, Eli Lilly and Company, GU20 6PH Windlesham, United Kingdom., Wu H; Bioinformatics Core Facility, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom., Möller-Levet CS; Bioinformatics Core Facility, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom., Laing EE; Department of Microbial Sciences, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom., Malki K; Lilly Research Centre, Erl Wood Manor, Eli Lilly and Company, GU20 6PH Windlesham, United Kingdom., Lawless N; Lilly Research Centre, Erl Wood Manor, Eli Lilly and Company, GU20 6PH Windlesham, United Kingdom., Wafford KA; Lilly Research Centre, Erl Wood Manor, Eli Lilly and Company, GU20 6PH Windlesham, United Kingdom., Dijk DJ; Surrey Sleep Research Centre, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom; d.j.dijk@surrey.ac.uk r.winsky-sommerer@surrey.ac.uk., Winsky-Sommerer R; Surrey Sleep Research Centre, Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Guildford, United Kingdom; d.j.dijk@surrey.ac.uk r.winsky-sommerer@surrey.ac.uk.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Feb 12; Vol. 116 (7), pp. 2733-2742. Date of Electronic Publication: 2019 Jan 25.
Autor:
Wood CM; School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom. Electronic address: christianwood7311@gmail.com., Wafford KA; Neuroscience Division, Eli Lilly & Co. Ltd., Windlesham, GU20 6PH, United Kingdom., McCarthy AP; Neuroscience Division, Eli Lilly & Co. Ltd., Windlesham, GU20 6PH, United Kingdom., Hewes N; Neuroscience Division, Eli Lilly & Co. Ltd., Windlesham, GU20 6PH, United Kingdom., Shanks E; Neuroscience Division, Eli Lilly & Co. Ltd., Windlesham, GU20 6PH, United Kingdom., Lodge D; School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom., Robinson ESJ; School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2018 Sep 15; Vol. 140, pp. 246-259. Date of Electronic Publication: 2018 Jul 11.
Autor:
McKillop LE; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK., Fisher SP; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK., Cui N; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK., Peirson SN; Sleep and Circadian Neuroscience Institute, Oxford Molecular Pathology Institute, Sir William Dunn School of Pathology, Oxford OX1 3RE, UK, and., Foster RG; Sleep and Circadian Neuroscience Institute, Oxford Molecular Pathology Institute, Sir William Dunn School of Pathology, Oxford OX1 3RE, UK, and., Wafford KA; Eli Lilly & Company Ltd, Erl Wood Manor, Windlesham, Surrey GU20 6PH, UK., Vyazovskiy VV; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK, vladyslav.vyazovskiy@dpag.ox.ac.uk.; Sleep and Circadian Neuroscience Institute, Oxford Molecular Pathology Institute, Sir William Dunn School of Pathology, Oxford OX1 3RE, UK, and.
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2018 Apr 18; Vol. 38 (16), pp. 3911-3928. Date of Electronic Publication: 2018 Mar 26.
Autor:
Bruns RF; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Mitchell SN; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Wafford KA; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Harper AJ; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Shanks EA; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Carter G; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., O'Neill MJ; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Murray TK; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Eastwood BJ; Lilly Research Laboratories, Eli Lilly & Co., Erl Wood Manor, United Kingdom., Schaus JM; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Beck JP; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Hao J; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Witkin JM; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Li X; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Chernet E; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Katner JS; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Wang H; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Ryder JW; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Masquelin ME; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Thompson LK; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Love PL; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Maren DL; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Falcone JF; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Menezes MM; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA., Zhang L; Shanghai ChemPartner, Pudong, Shanghai 201203, China., Yang CR; Shanghai ChemPartner, Pudong, Shanghai 201203, China., Svensson KA; Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address: svensson_kjell_a@lilly.com.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2018 Jan; Vol. 128, pp. 351-365. Date of Electronic Publication: 2017 Oct 26.